BackConduit Pharmaceuticals Overview
Conduit Pharmaceuticals Inc

Conduit Pharmaceuticals Discounted Cash Flow

Compare Conduit Pharmaceuticals's DCF valuation ($0.048) to today's market price.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.05

Current Fair Value

$0.05
↓ 60.5% Downside

Overvalued by 60.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading

Conduit Pharmaceuticals (CDT) FAQ

Conduit Pharmaceuticals (CDT) currently reports a DCF fair value of $0.048. Use the charts on this page to explore Conduit Pharmaceuticals's DCF fair value history and peer comparisons.

Conduit Pharmaceuticals's discounted cash flow (DCF) fair value estimate is $0.048, about 60.5% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.

Start with the current DCF fair value of $0.048, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Conduit Pharmaceuticals, and consider following CDT for alerts when major investors trade the stock.